A - Human Necessities – 01 – K
Patent
A - Human Necessities
01
K
A01K 63/00 (2006.01) A61K 48/00 (2006.01) A61K 49/00 (2006.01) C07K 14/71 (2006.01) C12N 1/20 (2006.01) C12N 5/00 (2006.01) C12N 5/02 (2006.01) C12N 15/00 (2006.01) C12N 15/09 (2006.01) C12N 15/63 (2006.01) C12N 15/70 (2006.01) C12N 15/74 (2006.01) C12P 21/04 (2006.01) G01N 33/50 (2006.01) G01N 33/53 (2006.01) G01N 33/567 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2360745
In vitro and in vivo screening assays for antagonists of fibroblast growth factor receptor (FGFR)-mediated malignant cell transformation are provided using stable cell lines genetically engineered to express a recombinant wild type or constitutively active mutant FGFR selected from FGFR1, FGFR2 and FGFR3, the malignant potential of said cell lines being modulated by said FGFR.
L'invention concerne des dosages par criblage, in vitro and in vivo, destinés à la recherche d'antagonistes de la transformation cellulaire induite par le récepteur du facteur de croissance du fibroblaste (FGFR), et dans lesquels on utilise des lignées cellulaires modifiées génétiquement de manière à exprimer un type sauvage recombiné ou un FGFR mutant, actif de manière constitutive, choisi parmi FGFR1, FGFR2 et FGFR3, le potentiel malin de ces lignées cellulaires étant modulé par ledit FGFR.
Ben-Levy Rachel
Reznitsky Dalya
Yayon Avner
Fetherstonhaugh & Co.
Prochon Biotech Ltd.
Yeda Research And Development Co. Ltd.
LandOfFree
Screening assay for antagonists of fgfr-mediated malignant... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening assay for antagonists of fgfr-mediated malignant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening assay for antagonists of fgfr-mediated malignant... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1395557